A play in four acts: Staphylococcus aureus abscess formation
- PMID: 21353779
- PMCID: PMC3087859
- DOI: 10.1016/j.tim.2011.01.007
A play in four acts: Staphylococcus aureus abscess formation
Abstract
Staphylococcus aureus is an important human pathogen that causes skin and soft tissue abscesses. Abscess formation is not unique to staphylococcal infection and purulent discharge has been widely considered a physiological feature of healing and tissue repair. Here we present a different view, whereby S. aureus deploys specific virulence factors to promote abscess lesions that are distinctive for this pathogen. In support of this model, only live S. aureus is able to form abscesses, requiring genes that act at one or more of four discrete stages during the development of these infectious lesions. Protein A and coagulases are distinctive virulence attributes for S. aureus, and humoral immune responses specific for these polypeptides provide protection against abscess formation in animal models of staphylococcal disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Alice Cheng, Andrea DeDent, Olaf Schneewind and Dominique Missiakas are named inventors on a patent owned by The University of Chicago, which is the subject of a license agreement with Novartis Vaccines and Diagnostics.
Figures
Similar articles
-
Contribution of Staphylococcus aureus Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and Soft Tissue Infection.PLoS One. 2016 Jun 23;11(6):e0158293. doi: 10.1371/journal.pone.0158293. eCollection 2016. PLoS One. 2016. PMID: 27336691 Free PMC article.
-
Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection.J Infect Dis. 2011 Sep 15;204(6):937-41. doi: 10.1093/infdis/jir441. J Infect Dis. 2011. PMID: 21849291 Free PMC article.
-
Persistence and progression of staphylococcal infection in the presence of public goods.NPJ Biofilms Microbiomes. 2020 Nov 27;6(1):55. doi: 10.1038/s41522-020-00168-2. NPJ Biofilms Microbiomes. 2020. PMID: 33247129 Free PMC article.
-
Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.Am J Clin Dermatol. 2018 Oct;19(5):671-677. doi: 10.1007/s40257-018-0362-9. Am J Clin Dermatol. 2018. PMID: 29882122 Review.
-
Staphylococcal Skin and Soft Tissue Infections.Infect Dis Clin North Am. 2021 Mar;35(1):81-105. doi: 10.1016/j.idc.2020.10.003. Epub 2020 Dec 7. Infect Dis Clin North Am. 2021. PMID: 33303329 Review.
Cited by
-
CCR2 contributes to host defense against Staphylococcus aureus orthopedic implant-associated infections in mice.J Orthop Res. 2022 Feb;40(2):409-419. doi: 10.1002/jor.25027. Epub 2021 Mar 29. J Orthop Res. 2022. PMID: 33713394 Free PMC article.
-
MALDI TIMS IMS Reveals Ganglioside Molecular Diversity within Murine S. aureus Kidney Tissue Abscesses.J Am Soc Mass Spectrom. 2024 Aug 7;35(8):1692-1701. doi: 10.1021/jasms.4c00089. Epub 2024 Jul 25. J Am Soc Mass Spectrom. 2024. PMID: 39052897 Free PMC article.
-
Murine Models for Staphylococcal Infection.Curr Protoc. 2021 Mar;1(3):e52. doi: 10.1002/cpz1.52. Curr Protoc. 2021. PMID: 33656290 Free PMC article.
-
RpiRc Is a Pleiotropic Effector of Virulence Determinant Synthesis and Attenuates Pathogenicity in Staphylococcus aureus.Infect Immun. 2016 Jun 23;84(7):2031-2041. doi: 10.1128/IAI.00285-16. Print 2016 Jul. Infect Immun. 2016. PMID: 27113358 Free PMC article.
-
Staphylococcus aureus Multiplexes Death-Effector Deoxyribonucleosides to Neutralize Phagocytes.Front Immunol. 2022 Mar 10;13:847171. doi: 10.3389/fimmu.2022.847171. eCollection 2022. Front Immunol. 2022. PMID: 35355997 Free PMC article.
References
-
- Kloos W, et al. The genus Staphylococcus. In: Balows A, et al., editors. The prokaryotes. Springer-Verlag; 1992. pp. 1369–1420.
-
- Götz F, et al. The Genera Staphylococcus and Macrococcus. In: Dworkin M, et al., editors. The Prokaryotes. Springer; New York: 2006. pp. 5–75.
-
- Lowy FD. Staphylococcus aureus infections. New Engl J Med. 1998;339:520–532. - PubMed
-
- Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med. 1989;320:1188–1199. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- T32 GM007281-35/GM/NIGMS NIH HHS/United States
- R01 AI052474-09/AI/NIAID NIH HHS/United States
- U54 AI057153-07/AI/NIAID NIH HHS/United States
- GM07281/GM/NIGMS NIH HHS/United States
- 1-U54-AI-057153/AI/NIAID NIH HHS/United States
- AI52474/AI/NIAID NIH HHS/United States
- R01 AI075258/AI/NIAID NIH HHS/United States
- R01 AI075258-04/AI/NIAID NIH HHS/United States
- U54 AI057153/AI/NIAID NIH HHS/United States
- AI75258/AI/NIAID NIH HHS/United States
- T32 GM007281/GM/NIGMS NIH HHS/United States
- R01 AI052474/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
